This article has Open Peer Review reports available.
Cervical adenocarcinoma presenting as a cardiac tamponade in a 57-year-old woman: a case report
© Azria et al; licensee BioMed Central Ltd. 2011
Received: 14 August 2011
Accepted: 21 December 2011
Published: 21 December 2011
Pericardial effusion as a complication of malignant gynecological disorders is rare. Few cases of endometrial cancer, squamous cell carcinoma of the cervix, ovarian cancer and uterine carcinosarcoma have been previously reported. We report the first case of cardiac tamponade secondary to a cervical adenocarcinoma.
A 54-year-old Caucasian woman, without any relevant medical history and no gynecological aftercare, was admitted to our hospital emergency room with severe dyspnea. Echocardiography revealed severe pericardial effusion with a swinging heart. An emergency pericardial drainage was performed through a pericardial window, which permitted the draining of 700 mL of bloody fluid and a pericardial biopsy. Cytological examination of the fluid revealed atypical cells, and the biopsy specimen showed tumor emboli suggestive of adenocarcinoma. Magnetic resonance imaging showed a 35 mm cervical lesion indicative of an endocervical tumor. Exploratory laparoscopy revealed diffuse peritoneal lesions and histological examination of cervical curettage showed a poorly differentiated micropapillary adenocarcinoma of the cervix.
Carcinomatous pericarditis as the first symptom of a malignant gynecological adenocarcinoma has not, to the best of our knowledge, been documented before. This case highlights the extreme severity of pericardial effusion secondary to cervical adenocarcinoma, a sign of advanced disease. Gynecological malignancies have to be considered in cases of neoplastic pericardial effusion.
Cardiac tamponade as a complication of a malignant gynecological disorder is a very rare occurrence. Very few cases of malignant pericardial effusion due to endometrial cancer [1–4], squamous cell carcinoma of the cervix [5–9], ovarian cancer  or uterine carcinosarcoma  have been reported. We report a case of cervical adenocarcinoma revealed by symptoms of cardiac tamponade.
A 54-year-old Caucasian woman, without any relevant medical history and no gynecological aftercare, was admitted to our hospital emergency room with dyspnea that had progressed over 10 days and was worsening. Upon admission, we noted blood oxygen saturation of 89%, tachycardia (125 beats per minute) and hyperthermia (38.9°C). Her blood pressure was 120/80 mmHg. Electrocardiography showed sinus tachycardia and echocardiography revealed severe pericardial effusion with a swinging heart. An emergency subxiphoid incision with pericardial drainage was performed through a pericardial window, which permitted draining of 700 mL of bloody fluid and a pericardial biopsy. Cytological examination of the fluid revealed atypical cells, and the biopsy specimen showed tumor emboli suggestive of adenocarcinoma. Immunostaining indicated elevated levels of tumor marker, cytokeratin 7 (CK7). Her blood concentrations of carbohydrate antigen (CA) 125 and CA 15.3 were 4667 IU/L and 451 IU/L, respectively, suggesting ovarian malignancy.
Malignant neoplasia from any organ can potentially metastasize to the pericardium , but there are few data concerning pericardial metastasis of gynecological cancer and most are regarding ovarian carcinoma . In our review of the literature, we identified four reported cases of endometrial adenocarcinoma metastasizing to the pericardium, diagnosed antemortem [1–4], but none of cervical adenocarcinoma. Pericardial involvement is usually silent clinically and is often noticed only on postmortem examination , but it can also cause effusion and, rarely, tamponade [1, 2]. In an autopsy series of 11,432 patients reported by Butany et al. , a total of 264 patients were found with cardiac metastases. The primary neoplasm was gynecological in only two (< 1%) of these cases. The cardiac tissue involved was pericardium in most cases. The pericardium is rarely the only location of metastatic spread from the primary tumor , and is suggestive of disseminated disease. In our case, it was for this reason and because of the immunostaining appearance of the pericardial biopsy, that exploratory laparoscopy was performed, which showed peritoneal carcinosis.
When symptomatic, pericardial metastases tend to occur as secondary manifestations of the cancer [2, 3, 6, 11]. Carcinomatous pericarditis as the first symptom of a malignant gynecological adenocarcinoma has not, to our knowledge, been documented before.
Where medium-term follow-up has been reported, the outcome of patients with endometrium adenocarcinoma with pericardial effusion was progression to death in two of the four reported cases [1, 3]. In the two other cases, patients were alive at six-month follow-up [2, 4]. For our patient, the interval between tamponade and death was very short (33 days).
According to our findings and previous reports, cardiac tamponade can be considered as indicative of a very poor prognosis when it complicates the progression of a cervical or endometrial adenocarcinoma.
This case highlights the extreme severity of pericardial effusion secondary to cervical adenocarcinoma, a sign of advanced disease. Gynecological malignancies have to be considered in cases of neoplastic pericardial effusion.
Written informed consent for publication could not be obtained from any immediate relatives despite all reasonable attempts. Every effort has been made to protect the identity of our patient and there is no reason to believe that any of her immediate relatives would object to publication.
- Hayashi Y, Iwasaka T, Hachisuga T, Kishikawa T, Ikeda N, Sugimori H: Malignant pericardial effusion in endometrial adenocarcinoma. Gynecol Oncol. 1988, 29: 234-239. 10.1016/0090-8258(88)90218-1.View ArticlePubMedGoogle Scholar
- Kheterpal P, Singh M, Mondul A, Dharmarajan L, Soni A: Malignant pericardial effusion and cardiac tamponade in endometrial adenocarcinoma. Gynecol Oncol. 2001, 83: 143-145. 10.1006/gyno.2001.6340.View ArticlePubMedGoogle Scholar
- Kogan J, Golzman B, Turkot S, Ben-Dor D, Charkowsky T, Oren S: Malignant pericardial effusion and cardiac tamponade as a late complication of endometrial carcinoma. Eur J Intern Med. 2004, 15: 318-320. 10.1016/j.ejim.2004.02.005.View ArticlePubMedGoogle Scholar
- Santala M, Puistola U, Kauppila A: Endometrial adenocarcinoma complicated by malignant pericardial effusion. Gynecol Oncol. 1995, 56: 444-445. 10.1006/gyno.1995.1078.View ArticlePubMedGoogle Scholar
- Curry JL, Wojcik EM: Malignant pericardial effusion with metastatic squamous-cell carcinoma: discordance between ThinPrep and cell-block cytopreparation. Diagn Cytopathol. 2003, 29: 270-10.1002/dc.10327.View ArticlePubMedGoogle Scholar
- Jamshed A, Khafaga Y, El-Husseiny G, Gray AJ, Manji M: Pericardial metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 1996, 61: 451-453. 10.1006/gyno.1996.0174.View ArticlePubMedGoogle Scholar
- Nelson BE, Rose PG: Malignant pericardial effusion from squamous cell cancer of the cervix. J Surg Oncol. 1993, 52: 203-206. 10.1002/jso.2930520318.View ArticlePubMedGoogle Scholar
- Rieke JW, Kapp DS: Successful management of malignant pericardial effusion in metastatic squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1988, 31: 338-351. 10.1016/S0090-8258(88)80013-1.View ArticlePubMedGoogle Scholar
- Rudoff J, Percy R, Benrubi G, Ostrowski ML: Recurrent squamous cell carcinoma of the cervix presenting as cardiac tamponade: case report and subject review. Gynecol Oncol. 1989, 34: 226-231. 10.1016/0090-8258(89)90148-0.View ArticlePubMedGoogle Scholar
- Forslund T, Forsen KO, Maenpaa J: Cardiac tamponade due to ovarian carcinoma. Arch Gynecol Obstet. 1991, 248: 161-165. 10.1007/BF02390095.View ArticlePubMedGoogle Scholar
- Shimizu S, Yajima M, Yoshii A, Nishikawa T, Ohta H: Malignant pericardial effusion and cardiac tamponade originating from uterine carcinosarcoma. Arch Gynecol Obstet. 2009, 279: 373-375. 10.1007/s00404-008-0701-9.View ArticlePubMedGoogle Scholar
- Reynen K, Kockeritz U, Strasser RH: Metastases to the heart. Ann Oncol. 2004, 15: 375-381. 10.1093/annonc/mdh086.View ArticlePubMedGoogle Scholar
- Tsang TS, Seward JB, Barnes ME, Bailey KR, Sinak LJ, Urban LH, Hayes SN: Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc. 2000, 75: 248-253. 10.4065/75.3.248.View ArticlePubMedGoogle Scholar
- Butany J, Leong SW, Carmichael K, Komeda M: A 30-year analysis of cardiac neoplasms at autopsy. Can J Cardiol. 2005, 21: 675-680.PubMedGoogle Scholar
- Sarjeant JM, Butany J, Cusimano RJ: Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs. 2003, 3: 407-421. 10.2165/00129784-200303060-00004.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.